Trends in Glucocerebrosides Research: A Systematic Review

Trends in Glucocerebrosides Research: A Systematic Review

Glucocerebrosides are sphingolipid components of cell membranes that intervene in numerous cell biological processes and signaling pathways and that deregulation is implicated in human diseases such as Gaucher disease and Parkinson's disease. In the present study, we conducted a systematic revi...

Full description

Bibliographic Details
Main Authors:	Mazarine Desplanque, Marie-Amandine Bonte, Bernard Gressier, David Devos, Marie-Christine Chartier-Harlin, Karim Belarbi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Frontiers in Physiology
Subjects:	cancer drug resistance gangliosides gaucher disease glucocerebrosides glucosylceramides lipids
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2020.558090/full

Similar Items

Glucocerebroside reduces endothelial progenitor cell-induced angiogenesis
by: Hsiang-Ping Lee, et al.
Published: (2019-01-01)

Epidermal sphingomyelins are precursors for selected stratum corneum ceramides
by: Yoshikazu Uchida, et al.
Published: (2000-12-01)

Hemorrhagic Aspects of Gaucher Disease
by: Hanna Rsenbaum
Published: (2014-10-01)

A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer’s Disease
by: Fatima El Idrissi, et al.
Published: (2021-07-01)

NADPH oxidases in Parkinson’s disease: a systematic review
by: Karim Belarbi, et al.
Published: (2017-11-01)

Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals[S]
by: Johanna von Gerichten, et al.
Published: (2017-06-01)

Gaucher′s disease
by: Vijay Bohra, et al.
Published: (2011-01-01)

Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.
by: Lindsey T. Lelieveld, et al.
Published: (2022-05-01)

Preparative isolation of cerebrosides (galactosyl and glucosyl ceramide)
by: N S Radin
Published: (1976-05-01)

A Brazilian Rare-Disease Center’s Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF
by: Matheus Vernet Machado Bressan Wilke, et al.
Published: (2024-03-01)

Lysosomal membrane integrity in fibroblasts derived from patients with Gaucher disease
by: Asuka Hamamoto, et al.
Published: (2023-12-01)

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
by: Wendy Westbroek, et al.
Published: (2016-07-01)

β-Glucocerebrosidase Deficiency Activates an Aberrant Lysosome-Plasma Membrane Axis Responsible for the Onset of Neurodegeneration
by: Giulia Lunghi, et al.
Published: (2022-07-01)

Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment
by: Aizeddin Mhanni, et al.
Published: (2020-01-01)

Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride
by: Jacques Bodennec, et al.
Published: (2003-07-01)

GBA Regulates EMT/MET and Chemoresistance in Squamous Cell Carcinoma Cells by Modulating the Cellular Glycosphingolipid Profile
by: Laura E. Clark, et al.
Published: (2023-07-01)

Quantification of glucosylceramide in plasma of Gaucher disease patients
by: Maria Viviane Gomes Muller, et al.
Published: (2010-12-01)

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease
by: Marcus O.W. Grimm, et al.
Published: (2014-06-01)

Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis
by: Sharon Melamed, et al.
Published: (2020-08-01)

Enhanced calcium release in the acute neuronopathic form of Gaucher disease
by: Dori Pelled, et al.
Published: (2005-02-01)

Glycosphingolipids are linked to elevated neurotransmission and neurodegeneration in a Drosophila model of Niemann Pick type C
by: Anna E. Eberwein, et al.
Published: (2023-10-01)

β-Glucocerebrosidase activity in mammalian stratum corneum
by: Yutaka Takagi, et al.
Published: (1999-05-01)

Avaliação de dois anos de tratamento da doença de Gaucher tipo 1 com terapia de reposição enzimática em pacientes do estado de São Paulo, Brasil Evaluation of two years of treatment with enzyme replacement therapy in type 1 Gaucher disease patients of São Paulo State, Brazil
by: Elisa A. P. Sobreira, et al.
Published: (2008-01-01)

Phytochemical investigation of unripe banana (Musa AAB) cv. Nendran and its novel ‘Banana Grits’
by: Natakkakath Kaliyathan Raveena, et al.
Published: (2022-10-01)

Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent
by: Tomer Adar, et al.
Published: (2022-04-01)

Podocyte Pathology and Nephropathy
by: Sandra eMerscher, et al.
Published: (2014-07-01)

Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors
by: Cécile Baudoin-Dehoux, et al.
Published: (2019-01-01)

Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases[S]
by: AndréR.A. Marques, et al.
Published: (2016-03-01)

Neutral glycolipids in leukemic and nonleukemic leukocytes
by: J. HILDEBRAND, et al.
Published: (1971-05-01)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
by: Zoran V. Popovic, et al.
Published: (2017-07-01)

Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
by: Natsuki Kita, et al.
Published: (2024-03-01)

Bone marrow adipocytes alteration in an in vitro model of Gaucher Disease
by: A. Crivaro, et al.
Published: (2023-09-01)

Role of μ-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish
by: Lindsey T. Lelieveld, et al.
Published: (2019-11-01)

Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
by: Elodie Cuvelier, et al.
Published: (2018-10-01)

The metabolism of glucocerebrosides - From 1965 to the present.
by: Futerman, A, et al.
Published: (2016)

Differential Ganglioside and Cholesterol Depletion by Various Cyclodextrin Derivatives and Their Effect on Synaptosomal Glutamate Release
by: Orsolya Geda, et al.
Published: (2022-08-01)

In Vitro and In Vivo Anti-inflammatory Activity of Bovine Milkfat Globule (MFGM)-derived Complex Lipid Fractions
by: Kate P. Palmano, et al.
Published: (2020-07-01)

Lipid rafts and human diseases: why we need to target gangliosides
by: Jacques Fantini
Published: (2023-09-01)

Editorial: Phospholipids and sphingolipids in nutrition, metabolism, and health
by: Ronan Lordan, et al.
Published: (2023-02-01)

The Missing Link - Likely Pathogenetic Role of GM3 and Other Gangliosides in the Development of Diabetic Nephropathy
by: Igor Vukovic, et al.
Published: (2015-05-01)